Numerous systemic investigations involving a series of genes have been performed in AML using first or second generation of sequencing techniques, and prognostic value has been analyzed, especially for the most common ones, such as NPM1, CEBPA, FLT3 etc. [11, 13, 47]. The gene discussed is NPM1; the disease is acute myeloid leukemia.